Gene · 6582
Papers2,540
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 2,540
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Enhanced Antibacterial Activity of Novel Fluorescent Glutathione-Capped Ag Nanoclusters. | Int J Mol Sci | 2023 | 37176012 | PubTator, text mining | PubMed |
| Progress in the Quantitative Assessment of Transporter-Mediated Drug-Drug Interactions Using Endogenous Substrates in Clinical Studies. | Drug Metab Dispos | 2023 | 37169512 | PubTator, text mining | PubMed |
| Absence of Clinically Meaningful Drug-Drug Interactions with Rezafungin: Outcome of Investigations. | Microbiol Spectr | 2023 | 37154682 | PubTator, text mining | PubMed |
| Genetic polymorphism related to ethambutol outcomes and susceptibility to toxicity. | Front Genet | 2023 | 37152993 | PubTator, text mining | PubMed |
| The Clinical Application and Progress of Mirogabalin on Neuropathic Pain as a Novel Selective Gabapentinoids. | Mediators Inflamm | 2023 | 37152369 | PubTator, text mining | PubMed |
| The Effect of Trimethoprim on Thiamine Absorption: A Transporter-Mediated Drug-Nutrient Interaction. | Clin Pharmacol Ther | 2023 | 37151050 | PubTator, text mining | PubMed |
| In vitro validation of an in vivo phenotyping drug cocktail for major drug transporters in humans. | Eur J Pharm Sci | 2023 | 37142000 | PubTator, text mining | PubMed |
| Pretreatment of ellagic acid protects ifosfamide-induced acute nephrotoxicity in rat kidneys: A mitochondrial, histopathological and oxidative stress approaches. | Toxicol Rep | 2023 | 37125148 | PubTator, text mining | PubMed |
| Overcoming Biological Barriers: Importance of Membrane Transporters in Homeostasis, Disease and Disease Treatment. | Int J Mol Sci | 2023 | 37108379 | PubTator, text mining | PubMed |
| Assessment of the Antioxidant and Antimicrobial Potential of Ptychotis verticillata Duby Essential Oil from Eastern Morocco: An In Vitro and In Silico Analysis. | Antibiotics (Basel) | 2023 | 37107017 | PubTator, text mining | PubMed |
| Integrative genetic analysis identifies FLVCR1 as a plasma-membrane choline transporter in mammals. | Cell Metab | 2023 | 37100056 | PubTator, text mining | PubMed |
| Pharmacogenetics of tenofovir renal toxicity in HIV-positive Southern Africans. | Pharmacogenet Genomics | 2023 | 37099271 | PubTator, text mining | PubMed |
| Comparison of Renal Functions Evaluated by Measured Glomerular Filtration Rate in Patients Treated With Cisplatin, Carboplatin, and Oxaliplatin. | Cureus | 2023 | 37095803 | PubTator, text mining | PubMed |
| Strong inhibition of organic cation transporter 2 by flavonoids and attenuation effects on cisplatin-induced cytotoxicity. | Chem Biol Interact | 2023 | 37084994 | PubTator, text mining | PubMed |
| Towards designing of a potential new HIV-1 protease inhibitor using QSAR study in combination with Molecular docking and Molecular dynamics simulations. | PLoS One | 2023 | 37079533 | PubTator, text mining | PubMed |
| Potential therapeutic effects of Chinese meteria medica in mitigating drug-induced acute kidney injury. | Front Pharmacol | 2023 | 37077810 | PubTator, text mining | PubMed |
| Genetic variation in organic cation transporters and considerations in drug development. | Expert Opin Drug Metab Toxicol | 2023 | 37070463 | PubTator, text mining | PubMed |
| Association of SLC11A1 polymorphisms with anthropometric and biochemical parameters describing Type 2 Diabetes Mellitus. | Sci Rep | 2023 | 37062790 | PubTator, text mining | PubMed |
| Inhibitory interaction of flavonoids with organic cation transporter 2 and their structure-activity relationships for predicting nephroprotective effects. | J Appl Toxicol | 2023 | 37057715 | PubTator, text mining | PubMed |
| The Battlefield of Chemotherapy in Pediatric Cancers. | Cancers (Basel) | 2023 | 37046624 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6582/papers?page=14